Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-09

FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved Zydus Lifesciences Limited's original ANDA for sacubitril/valsartan as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacubitril and valsartan (sacubitril/valsartan)

Snippet

ORIG AP for SACUBITRIL AND VALSARTAN (SACUBITRIL AND VALSARTAN)